Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-10 01:38:52 EDT

Explore

PostsPeople
LatestRanked
@healioguidance.bsky.socialOct 8, 2026, 5:36 PM

🔎Treating patients with atopic dermatitis?

We have what you need to know.

Use our module to help you:
• evaluate environmental risk factors;
• implement phototherapy or oral systemic therapy; and
• review treatment guidelines.

vist.ly/5mk9k

#AtopicDermatitis

@optometryadvisor.bsky.socialOct 6, 2026, 6:15 PM

Patients with moderate-to-severe #AtopicDermatitis treated with #Dupilumab may have elevated risk of developing ocular adverse effects, particularly those affecting the ocular surface, according to research published in Clinical Science.

Learn more: https://bit.ly/47BRIGJ

@thejidinnovations.bsky.socialOct 6, 2026, 12:00 PM

Read the review article by Wu et al:
Current research landscape and future prospects of in silico modeling approaches for #atopicdermatitis
https://doi.org/10.1016/j.xjidi.2026.100513
#DermatologyJournal #Dermatology #derm #dermatologist #dermresearch #dermscience #dermatologyresearch

@sevapediatrics.bsky.socialOct 6, 2026, 9:34 AM

#ChildhoodEczema #ToddlerEczema #NaturalEczemaRelief #BabyEczema #AtopicDermatitis #EczemaTriggers #KidsSkincare #ToddlerEczemaTriggers #EczemaFlareUps #BabySensitiveSkin #CentralTexasKids #KidsSkinAllergies #ChildSkinRash

sevapediatrics.com/childhood-ec...

@antibodytx.bsky.socialOct 5, 2026, 2:12 PM

Antibody Therapeutics (IF=4.8, Oxford University Press) ⚡ Research Highlight - GB12-09, a bispecific antibody targeting IL4Rα and IL31Rα for atopic dermatitis therapy.
doi.org/10.1093/abt/...
#bispecificantibodies #bsab #bsabs #atopicdermatitis #th2cytokines #il4rα #il31rα

@dermatologyadvisor.bsky.socialOct 1, 2026, 3:19 PM

#Dupilumab therapy in pediatric patients with moderate to severe #AtopicDermatitis is associated with meaningful increases in weight & #BMI. #EADV2026

https://www.dermatologyadvisor.com/reports/dupilumab-pediatric-ad-associated-with-weight-bmi-increases/

@pharmaphorum.bsky.socialSep 30, 2026, 2:47 PM

#AbbVie's long-acting anti-IL-13 antibody #zumilokibart – the main asset in its $10.9 billion takeover of Apogee Therapeutics – has hit the mark in a phase 2b trial in #atopicdermatitis, its lead indication.

pharmaphorum.com/news/apogee-...

@singsongraptor.bsky.socialSep 24, 2026, 11:30 PM

Can anyone give recommendations on a hypoallergenic liquid hand soap? Bonus if there's a portable version I could take to school? I'll put it in a bottle with a flip cap if I have to

#disability #atopicdermatitis #soap #allergies

@dermimmuno.bsky.socialSep 23, 2026, 1:42 AM

In a phase 3 trial, #ivarmacitinib was associated with improved skin signs and itch for adolescents and adults with moderate to severe #AtopicDermatitis. #Dermatology

🌟 Read the full article here:
www.docwirenews.com/post/long-te...

@dermatologyadvisor.bsky.socialSep 22, 2026, 12:48 PM

In children with moderate to severe #AtopicDermatitis, 62% of boys and 48% of girls were below the 50th percentile for height, whereas 50% and 51%, were above the 50th percentile for weight.

https://www.dermatologyadvisor.com/news/moderate-severe-atopic-dermatitis-linked-reduced-growth-children/

@kill-bait.bsky.socialSep 18, 2026, 6:41 PM

Early Skin Microbiome Changes Are Associated With Later Atopic Disease in Infants

🤖 IA: It's not clickbait ✅
👥 Users: It's not clickbait ✅

#skinmicrobiome #atopicdermatitis #infants

👇👇👇

@aafanational.bsky.socialSep 18, 2026, 1:44 PM

Clinicians: Earn Free #CME credit on #AtopicDermatitis (AD). Topics discussed:

➡️ How long-term management of AD is essential for improving outcomes
➡️ Advanced therapies to manage AD
➡️ Improving treatment adherence and outcomes

Watch now: https://bit.ly/4vlPZ1T

@swhr.bsky.socialSep 14, 2026, 5:05 PM

#AtopicDermatitis, a form of #eczema, causes more than dry, itchy skin – it can also put individuals at a higher risk of #anxiety and #depression. During #NationalEczemaWeek, learn more about this #ChronicDisease in our fact sheet: https://ow.ly/tjs050ZLxIc. #SWHRtalksAutoimmune

@charityeos.bsky.socialSep 14, 2026, 10:30 AM

Read the 2026 study insights
👉 https://ow.ly/WSQz50ZIjnt This #WorldAtopicEczemaDay , we’re highlighting new research exploring the connection between #atopicdermatitis and #eosinophilicesophagitis. Discover why this connection matters. #BreakTheInvisibleBurden #SkinAllergy

@allergy-eaaci.bsky.socialSep 14, 2026, 6:31 AM

#Atopicdermatitis, also known as eczematous dermatitis and atopic #eczema, is a skin disease characterized by extremely itchy and irritated skin that poses a great burden to the patient.

1.	Fehr D, Flack N, Masenga G, et al. Dietary Habits and Atopic Dermatitis Significantly Influence the Fecal Microbiome. Allergy.n/a(n/a). https://doi.org/10.1111/all.70459

2.	Kim M, Del Duca E, Correa Da Rosa J, et al. Effect of Abrocitinib on the Skin Microbiome in Patients With Moderate-to-Severe Atopic Dermatitis. Allergy.n/a(n/a). https://doi.org/10.1111/all.70467

3.	Komatsu-Fujii T, Asahina R, Hasegawa T, et al. Initial OX40–OX40L Signaling Promotes a Skin-Resident Memory T-Cell Reservoir in Atopic Dermatitis. Allergy.n/a(n/a). https://doi.org/10.1111/all.70493

4.	Lally JS, Yoshida T, Gao S, et al. Serum-Proteomic Profiling Reveals Distinct Atopic Dermatitis Severity-Linked Signatures. Allergy.n/a(n/a).  
https://doi.org/10.1111/all.70464

5.	Lee JH, Lim SH, Kook H, et al. Mycosis Fungoides-Like Atopic Dermatitis Represents a Th22-Dominant Inflammatory Endotype. Allergy.n/a(n/a).  
https://doi.org/10.1111/all.70440

6.	Bhattacharyya M, Lauffer F, Jargosch M, et al. Skin Lipid-Microbe Interplay Links Staphylococcus hominis to Barrier Control in Adult Atopic Dermatitis. Allergy. 2026;81(2):454-467. https://doi.org/10.1111/all.70028

7.	Bieber T, Maintz L, Phad GE, Bruggen MC. From Disease Control to Disease Modification: The Atopic Dermatitis Disease Activity Index. Allergy. 2026;81(2):577-579.  https://doi.org/10.1111/all.70036

8.	Czarnowicki T, Sugita K, Yiu Z, et al. Divergent Paths: A Comprehensive Review of Mechanisms and Clinical Implications in Atopic Dermatitis and Psoriasis. Allergy. 2026;81(7):2309-2324.  https://doi.org/10.1111/all.70347

9.	D'Avino P, Kim J, Li M, et al. Distinct Roles of IL-4, IL-13, and IL-22 in Human Skin Barrier Dysfunction and Atopic Dermatitis. Allergy. 2026;81(2):480-497. https://doi.org/10.1111/all.70060

10.	de Bruin-Weller MS, Boesjes CM, Achten RA, et al. Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions. Allergy. 2026;81(2):326-344.  https://doi.org/10.1111/all.70061

#Allergy_journal
@allergy-eaaci.bsky.socialSep 13, 2026, 3:24 PM

Open access: Serum‐Proteomic Profiling Reveals Distinct #AtopicDermatitis Severity‐Linked Signatures. First author: Jag S. Lally; corresponding author: Anna De Benedetto
👉 doi.org/10.1111/all.70464

#Allergy_journal
More articles 👉 journalallergy.com/Atopic_Dermatitis_Urticaria_and_Skin_Disease


This study aimed to identify a set of serum biomarkers that robustly distinguish prespecified severe from mild atopic dermatitis groups. Serum proteomic profiling distinguishes severe from mild atopic dermatitis, revealing an epithelial-enriched severity footprint linked to lactate dehydrogenase (LDH)-associated tissue injury and Th2/Th22 inflammation. Machine learning identified a 9-protein biomarker signature that discriminated severity groups with high cross-validation accuracy (AUC = 0.989).
@apcmicrobiomeirel.bsky.socialSep 11, 2026, 9:00 AM

Three environmental, immune & gene activity patterns were linked with eczema in 217 children. New in @plosmedicine.org, with APC researchers.

Read: buff.ly/m7qZC5h
APC: buff.ly/IyoMZoV

#AtopicDermatitis #Eczema #MachineLearning #Immunology #Immunosky

@plosmedicine.org @uccmicrobiology.bsky.social

@dermatologyadvisor.bsky.socialSep 9, 2026, 8:10 PM

Adherence to 4 healthy lifestyle behaviors was associated with a lower incidence of adult-onset #AtopicDermatitis when compared with those who adhered to 0 or 1 behavior.

Read more: https://www.dermatologyadvisor.com/news/adherence-4-lifestyle-behaviors-may-lower-risk-incident-atopic-dermatitis/

@allergy-eaaci.bsky.socialSep 8, 2026, 5:11 PM

T. Komatsu-Fujii, R. Asahina, T. Hasegawa, et al., “ Initial OX40–OX40L Signaling Promotes a Skin-Resident Memory T-Cell Reservoir in #AtopicDermatitis,” 👉 doi.org/10.1111/all.70493

#Allergy_journal
Watch more videos 👉 journalallergy.com and youtube.com/@Allergy-TV

www.youtube.com/watch?v=jRP3...

@dermatologyadvisor.bsky.socialSep 3, 2026, 2:41 PM

At 2 years of treatment, 96.6% of those with moderate to severe #AtopicDermatitis reported meaningful benefit; 74.9% reported improvement in #pruritus relief — the highest rated priority.

https://www.dermatologyadvisor.com/news/pruritus-relief-patients-top-treatment-priority-for-moderate-severe-ad/